C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseaseP.M. Burger, Stefan Koudstaal, Arend Mosterd et al.|Journal of the American College of Cardiology|2023Cited by 134
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease LocationsP.M. Burger, Frank L.J. Visseren, Aruna D. Pradhan et al.|The American Journal of Cardiology|2023Cited by 66
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T.L. Fiolet, Peter J. Kelly, Yongjun Wang et al.|EClinicalMedicine|2024Cited by 56
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d’Entremont, Sanjit S. Jolly, Michiel H.F. Poorthuis et al.|European Heart Journal|2025Cited by 43
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trialsP.M. Burger, Frank L.J. Visseren, Jannick A N Dorresteijn et al.|Atherosclerosis|2024Cited by 36